CHI ADVISORS LLC Holdings

CHI ADVISORS LLC is an investment fund managing more than 371.91M US dollars. The largest holdings include Prometheus Biosciences, Pliant Therapeutics and Cullinan Oncology. In Q3 2022 the fund bought assets of total value of 77.12M US dollars and sold assets of total value of 33.91M US dollars.

CHI ADVISORS LLC portfolio value:

$371.90M
portfolio value

CHI ADVISORS LLC quarter portfolio value change:

+35.74%
quarter

CHI ADVISORS LLC 1 year portfolio value change:

-16.44%
1 year

CHI ADVISORS LLC 3 years portfolio value change:

-215.60%
3 years

CHI ADVISORS LLC portfolio changes

Portfolio changes (number of shares)
Period Buy Sel
Q4 2019 2657000 7563000
Q1 2020 -22851000 66996000
Q2 2020 219267000 5715000
Q3 2020 31977000 4637000
Q4 2020 64085000 2313000
Q1 2021 138968000 15922000
Q2 2021 -38020000 8991000
Q3 2021 -40508000 39604000
Q4 2021 -11327000 20919000
Q1 2022 -17421000 25120000
Q2 2022 35046000 1320000
Q3 2022 77115000 33912000

CHI ADVISORS LLC 13F holdings

Stock
Portfolio share: 25.42%
Portfolio value: 94.52M
Avg. open price: $36.39
Current price: $40
P/L: +9.92%
Sold -4.20% shares
Q3 2022
Portfolio share: 19.15%
Portfolio value: 71.23M
Avg. open price: $13.12
Current price: $17.83
P/L: +35.92%
Bought +9.75% shares
Q3 2022
Portfolio share: 11.18%
Portfolio value: 41.57M
Avg. open price: $16.24
Current price: $12.11
P/L: -25.42%
Bought +6.42% shares
Q3 2022
Portfolio share: 10.01%
Portfolio value: 37.23M
Avg. open price: $18.1
Current price: $17.32
P/L: -4.33%
Bought +15.98% shares
Q3 2022
Portfolio share: 6.65%
Portfolio value: 24.71M
Avg. open price: N/A
Current price: N/A
P/L: N/A
Bought +8.92% shares
Q3 2022
Portfolio share: 4.08%
Portfolio value: 15.17M
Avg. open price: $13.81
Current price: $7.43
P/L: -46.18%
Sold -4.24% shares
Q3 2022
Portfolio share: 2.94%
Portfolio value: 10.92M
Avg. open price: $1.96
Current price: $3.16
P/L: +61.22%
Bought +125.40% shares
Q3 2022
Portfolio share: 2.34%
Portfolio value: 8.70M
Avg. open price: $5.62
Current price: $13.29
P/L: +136.30%
Bought +54.09% shares
Q3 2022
Portfolio share: 2.07%
Portfolio value: 7.71M
Avg. open price: N/A
Current price: $16.04
P/L: N/A
Sold -35.31% shares
Q3 2022
Portfolio share: 2.03%
Portfolio value: 7.53M
Avg. open price: $40.65
Current price: $51.19
P/L: +25.93%
Bought +93.59% shares
Q3 2022
Portfolio share: 1.73%
Portfolio value: 6.45M
Avg. open price: N/A
Current price: $4.94
P/L: N/A
Sold -6.42% shares
Q1 2022
Portfolio share: 1.54%
Portfolio value: 5.72M
Avg. open price: N/A
Current price: $6.99
P/L: N/A
N/A
Q3 2021
Portfolio share: 1.44%
Portfolio value: 5.35M
Avg. open price: $4.09
Current price: $1.41
P/L: -65.53%
Sold -1.85% shares
Q3 2022
Portfolio share: 1.28%
Portfolio value: 4.77M
Avg. open price: $3.07
Current price: $1.34
P/L: -56.41%
Bought +22.34% shares
Q3 2022
Portfolio share: 1.16%
Portfolio value: 4.31M
Avg. open price: $9.49
Current price: $2.36
P/L: -75.14%
Bought +11.31% shares
Q3 2022
Portfolio share: 1.09%
Portfolio value: 4.04M
Avg. open price: $10.84
Current price: $6.16
P/L: -43.18%
Sold -57.78% shares
Q3 2022
Portfolio share: 1.07%
Portfolio value: 3.99M
Avg. open price: $1.95
Current price: $0.46
P/L: -76.48%
Bought +50.49% shares
Q3 2022
Portfolio share: 0.92%
Portfolio value: 3.42M
Avg. open price: $6.3
Current price: $4.53
P/L: -28.10%
Bought +139.53% shares
Q3 2022
Portfolio share: 0.91%
Portfolio value: 3.37M
Avg. open price: $2.51
Current price: $0.62
P/L: -75.27%
Sold -0.99% shares
Q3 2022
Portfolio share: 0.76%
Portfolio value: 2.81M
Avg. open price: N/A
Current price: $5.78
P/L: N/A
N/A
Q3 2022
Portfolio share: 0.54%
Portfolio value: 2.01M
Avg. open price: $10.64
Current price: $0.46
P/L: -95.68%
Sold -2.07% shares
Q2 2022
Portfolio share: 0.52%
Portfolio value: 1.95M
Avg. open price: $2.53
Current price: $1.02
P/L: -59.62%
Bought +7.69% shares
Q3 2022
Portfolio share: 0.43%
Portfolio value: 1.59M
Avg. open price: $4.03
Current price: $1.85
P/L: -54.08%
Bought +1.40% shares
Q2 2022
Portfolio share: 0.42%
Portfolio value: 1.54M
Avg. open price: N/A
Current price: $8.59
P/L: N/A
Sold -67.15% shares
Q3 2022
Portfolio share: 0.32%
Portfolio value: 1.19M
Avg. open price: N/A
Current price: $16.5
P/L: N/A
N/A
Q3 2022
Portfolio share: 0.00%
Portfolio value: 0
Avg. open price: N/A
Current price: $0.07
P/L: N/A
Sold -100.00% shares
Q3 2022
Portfolio share: 0.00%
Portfolio value: 0
Avg. open price: $13.81
Current price: $7.43
P/L: -46.18%
Sold -100.00% shares
Q3 2022
Portfolio share: 0.00%
Portfolio value: 0
Avg. open price: $6.3
Current price: $4.53
P/L: -28.10%
Sold -100.00% shares
Q3 2022
Portfolio share: 0.00%
Portfolio value: 0
Avg. open price: N/A
Current price: $18.31
P/L: N/A
Sold -100.00% shares
Q3 2022
Portfolio share: 0.00%
Portfolio value: 0
Avg. open price: N/A
Current price: $85.66
P/L: N/A
Sold -100.00% shares
Q3 2022

Showing TOP 30 CHI ADVISORS's 13F holdings.

Frequently Asked Questions (FAQ)

What is the biggest position of CHI ADVISORS LLC?

The biggest position of the CHI ADVISORS LLC is Prometheus Biosciences, Inc. (RXDX) with 25.42% portfolio share worth of 94.52M US dollars.

Top 5 CHI ADVISORS's holdings represent 72.41% of the portfolio:

  • Prometheus Biosciences, Inc. (RXDX)25.42%
  • Pliant Therapeutics, Inc. (PLRX)19.15%
  • Cullinan Oncology, Inc. (CGEM)11.18%
  • Repare Therapeutics Inc. (RPTX)10.01%
  • VECTIVBIO HLDG AG ()6.65%

Who is the portfolio manager of CHI ADVISORS LLC?

The portfolio manager of the CHI ADVISORS LLC is .

What is the total asset value of the CHI ADVISORS LLC portfolio?

CHI ADVISORS LLC total asset value (portfolio value) is 371.91M US dollars.

Who is ?

is the portfolio manager of the CHI ADVISORS LLC.

What is (CHI ADVISORS LLC) fund performance?

CHI ADVISORS's quarterly performance is +35.74%, annualy -16.44%. In the past 3 years, the value of 's portfolio has decreased by -216%.

What is the CHI ADVISORS LLC CIK?

CHI ADVISORS's Central Index Key is 0001791468 .